Psychiatric symptoms in Huntington's disease before diagnosis: The Predict-HD study

被引:288
作者
Duff, Kevin
Paulsen, Jane S.
Beglinger, Leigh J.
Langbehn, Douglas R.
Stout, Julie C.
机构
[1] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA
[3] Indiana Univ, Dept Psychol, Bloomington, IN USA
关键词
Huntington's disease; pre-diagnosis; psychiatric symptoms;
D O I
10.1016/j.biopsych.2006.11.034
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Psychiatric disturbances are relatively common in manifest Huntington's disease (HD), but less is known about these symptoms in the earliest phase of the illness. Methods: This study examined self-reported psychiatric symptoms in a large sample (N = 681) of prediagnosed individuals who show the gene expansion for HD ("expansion-positive") compared with a sample of individuals who do not show the gene expansion but are at risk for HD ("expansion-negative"). Results: Using baseline Symptom Checklist 90-Revised (SCL-90-R) data from the Predict-HD study, expansion-positive individuals reported significantly more psychiatric symptoms (e.g., depression, anxiety, obsessive-compulsiveness) than expansion-negative individuals.Within the expansion-positive group, individuals with more motor signs had higher levels of psychiatric symptoms.The SCL-90-R scores had stronger relationships with reported abilities to perform activities of daily living than other markers of HD. Finally, when companions of the expansion-positive individuals also completed the SCL-90-R on the participants, there was considerable consistency in the ratings of psychiatric symptoms. Conclusions: Subtle, subclinical psychiatric symptoms are present in this prediagnosed HD sample, even though most are estimated to be more than 10 years from HD diagnosis. As suggested by other research, these subtle symptoms might be the earliest markers of the disease; however, longitudinal data are needed.
引用
收藏
页码:1341 / 1346
页数:6
相关论文
共 23 条
[1]  
[Anonymous], 1989, QUANTIFICATION NEURO
[2]   Onset and rate of striatal atrophy in preclinical Huntington disease [J].
Aylward, EH ;
Sparks, BF ;
Field, KM ;
Yallapragada, V ;
Shpritz, BD ;
Rosenblatt, A ;
Brandt, J ;
Gourley, LM ;
Liang, K ;
Zhou, H ;
Margolis, RL ;
Ross, CA .
NEUROLOGY, 2004, 63 (01) :66-72
[3]   Longitudinal change in basal ganglia volume in patients with Huntington's disease [J].
Aylward, EH ;
Li, Q ;
Stine, OC ;
Ranen, N ;
Sherr, M ;
Barta, PE ;
Bylsma, FW ;
Pearlson, GD ;
Ross, CA .
NEUROLOGY, 1997, 48 (02) :394-399
[4]   Basal ganglia volume and proximity to onset in presymptomatic Huntington disease [J].
Aylward, EH ;
Codori, AM ;
Barta, PE ;
Pearlson, GD ;
Harris, GJ ;
Brandt, J .
ARCHIVES OF NEUROLOGY, 1996, 53 (12) :1293-1296
[5]   Psychiatric symptoms in neurologically asymptomatic Huntington's disease gene carriers:: a comparison with gene negative at risk subjects [J].
Berrios, GE ;
Wagle, AC ;
Marková, IS ;
Wagle, SA ;
Rosser, A ;
Hodges, JR .
ACTA PSYCHIATRICA SCANDINAVICA, 2002, 105 (03) :224-230
[6]   Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers [J].
Berrios, GE ;
Wagle, AC ;
Marková, IS ;
Wagle, SA ;
Ho, LW ;
Rubinsztein, DC ;
Whittaker, J ;
Ffrench-Constant, C ;
Kershaw, A ;
Rosser, A ;
Bak, T ;
Hodges, JR .
PSYCHIATRY RESEARCH, 2001, 102 (03) :217-225
[7]  
Brandt J, 1989, J Neuropsychiatry Clin Neurosci, V1, P195
[8]  
Derogatis L. R., 1975, The Symptom Checklist-90-R(SCL-90-R)
[9]   Unified Huntington's disease rating scale: Reliability and consistency [J].
Kieburtz, K ;
Penney, JB ;
Como, P ;
Ranen, N ;
Shoulson, I ;
Feigin, A ;
Abwender, D ;
Greenamyre, JT ;
Higgins, D ;
Marshall, FJ ;
Goldstein, J ;
Steinberg, K ;
Shih, C ;
Richard, I ;
Hickey, C ;
Zimmerman, C ;
Orme, C ;
Claude, K ;
Oakes, D ;
Sax, DS ;
Kim, A ;
Hersch, S ;
Jones, R ;
Auchus, A ;
Olsen, D ;
BisseyBlack, C ;
Rubin, A ;
Schwartz, R ;
Dubinsky, R ;
Mallonee, W ;
Gray, C ;
Godfrey, N ;
Suter, G ;
Shannon, KM ;
Stebbins, GT ;
Jaglin, JA ;
Marder, K ;
Taylor, S ;
Louis, E ;
Moskowitz, C ;
Thorne, D ;
Zubin, N ;
Wexler, N ;
Swenson, MR ;
Paulsen, J ;
Swerdlow, N ;
Albin, R ;
Wernette, C ;
Walker, F ;
Hunt, V .
MOVEMENT DISORDERS, 1996, 11 (02) :136-142
[10]   Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers [J].
Kirkwood, SC ;
Siemers, E ;
Stout, JC ;
Hodes, ME ;
Conneally, PM ;
Christian, JC ;
Foroud, T .
ARCHIVES OF NEUROLOGY, 1999, 56 (05) :563-568